tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Ken Trbovich, 14 are a BUY (73.68%), 4 are a HOLD (21.05%), 1 are a SELL (5.26%).
Analyst Ken Trbovich, currently employed carries an average stock price target met ratio of 52.78% that have a potential upside of 24.46% achieved within 229 days. Previously, Ken Trbovich worked at JANNEY.
Ken Trbovich’s has documented 43 price targets and ratings displayed on 4 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on ASRT, Assertio Therapeutics at 29-Aug-2018.
Analyst best performing recommendations are on CARA (CARA THERAPEUTIC).
The best stock recommendation documented was for CARA (CARA THERAPEUTIC) at 6/28/2017. The price target of $22 was fulfilled within 2 days with a profit of $4.95 (18.37%) receiving and performance score of 91.84.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$4
$2.97 (288.35%)
$4
10 months 19 days ago
(04-Jan-2024)
1/5 (20%)
$3.1 (344.44%)
184
Buy
$4
$2.97 (288.35%)
$6
1 years 20 days ago
(03-Nov-2023)
1/5 (20%)
$1.66 (70.94%)
289
Hold
$16
$14.89 (1341.44%)
$52
5 years 3 months 15 days ago
(08-Aug-2019)
1/5 (20%)
$4.76 (42.35%)
59
Hold
$12
$9.09 (312.37%)
$28
5 years 6 months 7 days ago
(16-May-2019)
9/12 (75%)
$5.34 (9.39%)
50
Buy
$40
6 years 2 months 25 days ago
(29-Aug-2018)
1/9 (11.11%)
$6.64 (19.90%)
120
What Year was the first public recommendation made by Ken Trbovich?
